Projecting early molecular signatures of AD through the convergence study of omics and AI

Projecting early molecular signatures of AD through the convergence study of omics and AI
The Korea Brain Research Institute (headed by Suh Pann-ghill) announced on July 24 the discovery that an increase in amyloid-beta in the brain alters cholesterol biosynthesis, which was found by Dr. Cheon Mookyung of KBRI through RNA-seq analysis data (omics) using AI.